XML 73 R63.htm IDEA: XBRL DOCUMENT v2.4.0.6
14. Segment Reporting (Details) (USD $)
 3 Months Ended 12 Months Ended
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Jun. 30, 2011
Mar. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Segment Reporting Information [Line Items]                      
Number Of Products And Services                 8,000    
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest                 $ 222,931,000 $ 235,762,000 $ 220,283,000
Net sales 573,800,000 498,700,000 510,400,000 486,300,000 550,200,000 516,500,000 521,700,000 485,100,000 2,069,235,000 2,073,529,000 1,927,118,000
Allocated interest expense                 (51,112,000) (53,135,000) (63,717,000)
Depreciation and amortization                 130,400,000 121,000,000 108,900,000
Segment profit                 257,200,000 295,156,000 284,009,000
Life Science [Member]
                      
Segment Reporting Information [Line Items]                      
Net sales                 688,400,000 694,700,000 648,100,000
Allocated interest expense                 13,100,000 14,000,000 17,100,000
Depreciation and amortization                 26,300,000 17,300,000 15,000,000
Segment profit                 11,400,000 45,700,000 51,100,000
Segment assets 353,100,000       357,400,000       353,100,000 357,400,000  
Capital expenditures                 17,300,000 15,400,000  
Clinical Diagnostics [Member]
                      
Segment Reporting Information [Line Items]                      
Net sales                 1,365,500,000 1,363,800,000 1,265,300,000
Allocated interest expense                 37,800,000 38,900,000 46,400,000
Depreciation and amortization                 92,900,000 93,200,000 84,900,000
Segment profit                 197,800,000 197,900,000 171,400,000
Segment assets 917,000,000       854,800,000       917,000,000 854,800,000  
Capital expenditures                 76,800,000 71,600,000  
All Other Segments [Member]
                      
Segment Reporting Information [Line Items]                      
Net sales                 15,300,000 15,000,000 13,700,000
Allocated interest expense                 200,000 200,000 200,000
Depreciation and amortization                 100,000 200,000 200,000
Segment profit                 1,600,000 1,200,000 1,400,000
Segment assets 4,400,000       5,700,000       4,400,000 5,700,000  
Capital expenditures                 100,000 0  
Reportable Segment [Member]
                      
Segment Reporting Information [Line Items]                      
Segment profit                 210,800,000 244,800,000 223,900,000
Segment assets $ 1,274,500,000       $ 1,217,900,000       $ 1,274,500,000 $ 1,217,900,000